Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sikemi Ibikunle"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Allogeneic hematopoietic stem cell transplantation (HSCT) provides the only potentially curative option for multiple hematological conditions. However, allogeneic HSCT outcomes rely on an optimal balance of effective immune recovery, minimal graft-ve
Externí odkaz:
https://doaj.org/article/83ed31b3982843328292c4b6685a1505
Publikováno v:
J Racial Ethn Health Disparities
Prior to embarking on a large descriptive evaluation of genetic/racial variations in symptom phenotype, we sought foundational information to determine racial differences in (1) feasibility (consent) and acceptability of collecting genomic samples, (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f271fe1d1f4d7f6d96698da86f5f46d9
https://pubmed.ncbi.nlm.nih.gov/33025420
https://pubmed.ncbi.nlm.nih.gov/33025420
Autor:
Shivani Kapoor, Sikemi Ibikunle, Maria R. Baer, Mario Scarpa, Andre Rush, Patrick R. Baldwin, Danilo Perrotti
Publikováno v:
Cancer Research. 78:834-834
Background: In 30% of acute myeloid leukemia (AML) patients, the presence of fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) causes constitutive FLT3 signaling, and these patients relapse rapidly following response to chemotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719bffc6cf786213c7781d6adbdc0063
https://doi.org/10.1158/1538-7445.am2018-834
https://doi.org/10.1158/1538-7445.am2018-834
Publikováno v:
Frontiers in Immunology; 2023, p01-11, 11p
Publikováno v:
Stem Cell Week; 12/22/2023, p867-867, 1p